Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles.
Gene therapy is an emerging alternative to conventional anti-HIV-1 drugs, and can potentially control the virus while alleviating major limitations of current approaches. Yet, HIV-1's ability to rapidly acquire mutations and escape therapy presents a critical challenge to any novel treatment pa...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-08-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC2920833?pdf=render |